Analysts' ratings for BioNTech (NASDAQ:BNTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 10 | 1 | 6 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 3 | 0 | 0 |
| 2M Ago | 6 | 1 | 2 | 0 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, and a low estimate of $96.00. Marking an increase of 19.2%, the current average surpasses the previous average price target of $110.94.
Exploring Analyst Ratings: An In-Depth Overview
The standing of BioNTech among financial experts becomes clear with a thorough analysis of recent analyst...
ログインすると全部閲覧できます。
ログイン
